CDX2 Antibody Clone: GR023 Concentrate
- Known as:
- CDX2 Antibody Clone: GR023 Concentrate
- Catalog number:
- 61-0186
- Product Quantity:
- 1 mL
- Category:
- -
- Supplier:
- Genemed
- Gene target:
- CDX2 Antibody Clone: GR023 Concentrate
Ask about this productRelated genes to: CDX2 Antibody Clone: GR023 Concentrate
- Gene:
- CDX2 NIH gene
- Name:
- caudal type homeobox 2
- Previous symbol:
- CDX3
- Synonyms:
- -
- Chromosome:
- 13q12.2
- Locus Type:
- gene with protein product
- Date approved:
- 1994-09-07
- Date modifiied:
- 2015-08-24
Related products to: CDX2 Antibody Clone: GR023 Concentrate
Related articles to: CDX2 Antibody Clone: GR023 Concentrate
- Kawasaki disease (KD), also known as mucocutaneous lymph node syndrome (MCLS), remains the leading cause of acquired heart disease in children younger than 5 years; coronary artery lesions (CALs) develop in 20-30% of untreated patients. Although environmental exposures have been implicated, evidence is inconclusive, and systematic analyses linking exposure profiles to KD-associated immune signatures are still lacking. Despite rising global incidence, the etiology remains unclear, and systematic exploration of potential associations between environmental exposure and KD immune signatures is insufficient. This study employed integrated multi-omics analysis to explore potential associations between perfluorooctane sulfonate (PFOS) exposure and KD immune transcriptomic signatures. By intersecting KD transcriptomic signatures with PFOS toxicological targets, we identified 83 candidate genes significantly enriched in immune-inflammatory pathways. Permutation testing demonstrated PFOS-specific enrichment compared with structurally related compounds (enrichment fold = 2.45; P < 0.001). Machine learning combined with SHAP analysis identified four candidate hub genes (ALPL, IL4R, PGD, SLC22A4) showing consistent expression patterns across independent cohorts. Computational molecular simulations predicted potential binding interfaces between PFOS and candidate proteins, with more favorable docking scores compared to non-fluorinated analogs (6.4-8.9 kcal/mol). Single-cell RNA sequencing revealed hub gene expression in CD14/CD16 Mono and CD8 T, which exhibited elevated PFOS response scores. Transcription factor network analysis predicted CEBPB and CDX2 as candidate regulators associated with hub gene expression, with their regulatory activities correlated with PFOS response scores (activity differences and score-dependent monotonic trends; both P < 2.2 × 10). These computational findings suggest potentially PFOS-associated transcriptomic signatures in KD, providing candidate targets for subsequent mechanistic validation and epidemiological studies. - Source: PubMed
Publication date: 2026/04/26
Quan JiaTu JuxiangLi DanZhang ZongliXue LishaLi TaoXi Shibing - Wnt/β-catenin-activated rosette-forming carcinoma (WARFC) is a recently proposed cutaneous tumor entity characterized by rosette formation, CDX2 expression, RB1 loss, and Wnt/β-catenin pathway activation. Extracutaneous counterparts of WARFC have not been documented to date. We report a distinctive case of lung carcinoma closely resembling WARFC. An 80-year-old man with a smoking history presented with a rapidly enlarging lung nodule. The resected tumor consisted of a rosette-forming large cell carcinoma with a trabecular pattern and lacking neuroendocrine marker expression, combined with squamous cell carcinoma. The rosette-forming component showed aberrant nuclear β-catenin expression, diffuse CDX2 expression, and RB1 loss. Targeted sequencing identified a pathogenic APC splice-site mutation. This case likely represents the pulmonary counterpart of cutaneous WARFC. Pulmonary WARFC should be considered in the differential diagnosis of large cell lung carcinoma with neuroendocrine morphology. - Source: PubMed
Publication date: 2026/04/30
Tsuji KentaroTakeuchi YasuhideFujimoto MasakazuKiyuna ShotaFukutome TakutoTeramoto YukiIto HiroakiJinnouchi KeitaOmura MoeKitagawa TakashiKayawake HidenaoYoshizawa AkihikoHaga Hironori - AFP-producing gastric carcinoma (AFPGC) is an uncommon but clinically aggressive subset of gastric cancer with a strong propensity for liver metastasis. Serum alpha-fetoprotein (AFP) is often markedly elevated, whereas tumor AFP immunostaining can be negative, which may complicate recognition and classification. - Source: PubMed
Publication date: 2026/04/13
Jin YuqiFu LinglinZhao YuhanTong ZiyanTan Yinuo - Ovarian metastases from colorectal carcinoma (CRC) are rare but have significant clinical implications, often resembling primary ovarian tumors. An incorrect diagnosis can result in delayed systemic therapy and surgical planning. - Source: PubMed
Salimiaghdam NasimYang XuebinLiang Hongyan - Morular metaplasia is a phenomenon described in neoplasms of various sites, including endometrioid neoplasms of the uterus and colonic tubular adenomas. Although of questionable biological significance, they may be confused with squamous differentiation/neoplasia or neuroendocrine lesions. - Source: PubMed
Publication date: 2026/04/25
Kennedy BenjaminJacob DeeptiBernal KerryTalmon Geoffrey